[Correlations of insulin resistance and neoplasms]
- PMID: 16888676
[Correlations of insulin resistance and neoplasms]
Abstract
Insulin resistance is a worldwide risk factor for the two most dangerous human disease groups; namely, for cardiovascular lesions and malignancies. The insulin resistance syndrome have five basic criteria: hyperglycemia, visceral obesity, elevated serum triglyceride level, low HDL-cholesterol level (dyslipidemia) and hypertension. Each of these criteria alone are risk factors for cancer, and they mean together a multiple risk. Insulin resistance of the liver, skeletal muscles, and fatty tissue leads to a reactive hyperinsulinemia by the increased secretory activity of the beta-cells. Insulin has diverse metabolic effects, and at the same time is a growth factor. It enhances the production and mitogenic activity of other, insulin-like growth factors, and leads to pathological cell proliferation. In the uncompensated phase of insulin resistance hyperglycemia appears, which promotes tumor genesis by several pathways. The elevated serum glucose level is advantageous for the increased DNA synthesis of the tumor cells. It provokes deliberation of free radicals, which will cause derangement of both the DNA and the enzymes having a role in the repair mechanisms. Hyperglycemia leads to a nonenzymatic glycation of protein structures, and the glycated products enhance the deliberation of free radicals, cytokines and growth factors. Insulin resistance means an enhanced risk for breast, pancreas, liver, colon, bladder, prostate and oral cavity cancers. The moderately increased fasting glucose level is also a risk factor for breast, stomach and colon cancers, even without manifestation of type 2 diabetes. Insulin resistance promotes tumor progression as well. In cancer patients with hyperglycemia or type 2 diabetes, the rate of tumor recurrence, metastatic spread and fatal outcome is higher as compared with the tumor patients without metabolic disease. The correlation between insulin resistance and tumor promotion reveals new possibilities in the prevention and treatment of cancer. The healthy diet, physical activity and weight loss increase insulin sensitivity, and decrease the risk for both cardiovascular diseases and malignancies.
Similar articles
-
Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.Panminerva Med. 2005 Dec;47(4):201-10. Panminerva Med. 2005. PMID: 16489319 Review.
-
Energy balance, physical activity, and cancer risk.Methods Mol Biol. 2009;472:57-88. doi: 10.1007/978-1-60327-492-0_3. Methods Mol Biol. 2009. PMID: 19107429 Review.
-
Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus.Am J Med. 2007 Mar;120(3 Suppl 1):S12-8. doi: 10.1016/j.amjmed.2007.01.003. Am J Med. 2007. PMID: 17320517 Review.
-
Vegan proteins may reduce risk of cancer, obesity, and cardiovascular disease by promoting increased glucagon activity.Med Hypotheses. 1999 Dec;53(6):459-85. doi: 10.1054/mehy.1999.0784. Med Hypotheses. 1999. PMID: 10687887
-
Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.Acta Diabetol. 2009 Jun;46(2):85-95. doi: 10.1007/s00592-009-0112-9. Epub 2009 Mar 26. Acta Diabetol. 2009. PMID: 19322513 Review.
Cited by
-
Serum 25(OH)D Levels Modify the Association between Triglyceride and IR: A Cross-Sectional Study.Int J Endocrinol. 2022 May 10;2022:5457087. doi: 10.1155/2022/5457087. eCollection 2022. Int J Endocrinol. 2022. PMID: 35592754 Free PMC article.
-
Significance of Serum Adiponectin and Insulin Resistance Levels in Diagnosis of Egyptian Patients with Chronic Liver Disease and HCC.Asian Pac J Cancer Prev. 2019 Jun 1;20(6):1833-1839. doi: 10.31557/APJCP.2019.20.6.1833. Asian Pac J Cancer Prev. 2019. PMID: 31244307 Free PMC article.
-
Hyperlipidemia and hyper glycaemia in Breast Cancer Patients is related to disease stage.Pak J Med Sci. 2018 Jan-Feb;34(1):209-214. doi: 10.12669/pjms.341.14841. Pak J Med Sci. 2018. PMID: 29643909 Free PMC article.
-
Metformin influences progression in diabetic glioblastoma patients.Strahlenther Onkol. 2015 Dec;191(12):928-35. doi: 10.1007/s00066-015-0884-5. Epub 2015 Sep 2. Strahlenther Onkol. 2015. PMID: 26329695
-
Diverse pathomechanisms leading to the breakdown of cellular estrogen surveillance and breast cancer development: new therapeutic strategies.Drug Des Devel Ther. 2014 Sep 11;8:1381-90. doi: 10.2147/DDDT.S70570. eCollection 2014. Drug Des Devel Ther. 2014. PMID: 25246776 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources